Official publication of Rawalpindi Medical University
Revolutionizing Aging: The Dawn of Longevity Medicine and Lifespan Extension

Supplementary Files

PDF

How to Cite

1.
Irfan A. Revolutionizing Aging: The Dawn of Longevity Medicine and Lifespan Extension. JRMC [Internet]. 2025 Mar. 29 [cited 2025 Apr. 24];29(1). Available from: https://journalrmc.com/index.php/JRMC/article/view/2897

Abstract

Ageing, conventionally measured as an inevitable biological process, is one of the major areas of leading-edge scientific research. Nowadays, the field of senolytics, telomere extension and other cellular rejuvenation techniques intended at tackling ageing at its foundation have been studied by scientists as potential new options for extending human life and refining health in later years.1

Senolytics, Aging Reversal and Signaling the End of Senescence

The class of drugs known as senolytics, which kill senescent cells, have seen great promise in preclinical and very early human trials. Senescent cells, also termed zombie cells, accumulate with a normal ageing process and contribute to inflammation, tissue malfunction, and age-related disease. Senolytics, the drugs that selectively remove these cells, improve health, reduce frailty and it might even extend life.2 Such drugs as dasatinib and quercetin have been effective in animal models and ongoing human trials in checking their lifelong impact on ageing-related disorders like osteoarthritis and cardiovascular failure. A strategy of senolytics has proven to be promising against age-related decline due to its ability to target specific pathways that allow senescent cells to persist and evade regular cell death. Senolytics can accomplish this by acting in BCL-2, PI3K/AKT, and p53/p21 pathways, restoring tissue homeostasis and decreasing chronic inflammation.3 Dasatinib, a renowned tyrosine kinase inhibitor initially developed for leukaemia, and Quercetin, an exceptional natural flavonoid with brilliant senolytic properties, are two of the most prominent senolytics. Often, these both work well synergistically to enhance each other’s effects. An alternative flavonoid, fisetin, also has great potential for extending lifespan in experimental mice. Additionally, Navitoclax was identified for its ability to induce apoptosis of senescent cells through a selection of BCL-2 family members.4

Telomere Extension: The Key to Cellular Immortality

Telomeres are sequences of DNA located at the end of chromosomes that degrade with each cell division, leading to cell dysfunction.  Telomerase, an enzyme that replaces telomeres, has been shown to extend the cellular lifespan and possibly reverse the ageing process in various studies.5 Current studies include gene therapy to increase telomerase activity, which has been successful in animal models. The main challenges are the potential for uncontrolled cell growth and cancer. Telomere extension offers a great prospect to enhance the quality of human life and increase the lifespan primarily through two ways. First, there is telomerase activation, a process that reverses the shortening of telomeres. Telomerase is a ribonucleoprotein that adds tandem repeats to the ends of telomeres.6 It is mostly inactive in somatic cells, but this is very important in stem cells, germline cells and cancer cells. Gene therapy or the use of tiny molecules such as TA-65 could perhaps be used to deliver telomerase to ageing cells and resuscitate it, or reactivate it and increase its activity. Other research has shown that specific nutrients and hormones can increase telomerase activity, so there may be other avenues to be explored to regrow cellular health as well.7

On the other hand, an interesting mechanism called Alternative Lengthening of Telomeres (ALT) is working independently from telomerase mainly in cancer cells. ALT allows cells to extend their telomeres by copying telomeric DNA from one chromosome to another by using DNA repair mechanisms, such as homologous recombination. Blocking ALT could be an important cancer research target since ALT inhibiting could do much to stop the infinite proliferation of cancer cells.8

 

Beyond Senolytics and Telomeres: Additional Promising Interventions

Other therapies are gaining popularity in longevity therapy, besides senolytics and telomere extension. Metabolic pathways have been shown to regulate lifespan when metformin and rapamycin are mimicking calorie restriction. In addition, there are great breakthroughs from regenerative medicine in the renewing of ageing organs and tissues, including stem cell therapy and tissue engineering.9

The Ethical and Social Consequences of Prolonged Lifespan

While these scientific advances are interesting, they involve equally or even more serious ethical and societal dismays. What will be the implications of being able to confidently dramatically postpone or even, in some cases, reverse ageing on the global dynamics of population, economic systems and health systems? To prevent a future in which only the wealthy can afford extended lifespans, anti-ageing medications must be available as well.10, 11

The Future of Longevity Medicine

Anti-ageing research has moved beyond the realm of science fiction. With continuous advances in biotechnology, the idea of reducing, halting, or even reversing parts of ageing is becoming more real. However, converting these discoveries into safe and effective medicines for general usage is still a considerable issue. As research advances, the focus must stay on guaranteeing not only a longer but a healthier life.12

The promise of healthy longevity is closer than ever, but it will necessitate careful consideration of scientific, ethical, and cultural issues. The next few decades could redefine what it means to be old, turning ageing from an unavoidable decline into a controlled, treatable condition.

https://doi.org/10.37939/jrmc.v29i1.2897

References

Voss A. Immortality Inc.: The Science and Business of Living Forever. eBookIt. Com; 2024 Dec 15.

Calabrò A, Accardi G, Aiello A, Caruso C, Galimberti D, Candore G. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies. International Journal of Molecular Sciences. 2024 Feb 1;25(3):1792. https://doi.org/10.3390/ijms25031792.

Zheng L, He S, Wang H, Li J, Liu Y, Liu S. Targeting cellular senescence in aging and age-related diseases: challenges, considerations, and the emerging role of senolytic and senomorphic therapies. Aging and disease. 2024 Feb 27;15(6):2554. https://doi.org/10.14336/AD.2024.0206

Escriche-Navarro B, Garrido E, Sancenón F, García-Fernández A, Martínez-Máñez R. A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells. Acta Biomaterialia. 2024 Mar 1;176:405-16. https://doi.org/10.1016/j.actbio.2024.01.002

Boccardi V, Marano L. Aging, cancer, and inflammation: the telomerase connection. International Journal of Molecular Sciences. 2024 Aug 5;25(15):8542. https://doi.org/10.3390/ijms25158542

Liu M, Zhang Y, Jian Y, Gu L, Zhang D, Zhou H, Wang Y, Xu ZX. The regulations of telomerase reverse transcriptase (TERT) in cancer. Cell Death & Disease. 2024 Jan 26;15(1):90. https://doi.org/10.1038/s41419-024-06454-7

Boccardi V, Polom J. Searching for Beauty and Health: Aging in Women, Nutrition, and the Secret in Telomeres. Nutrients. 2024 Sep 15;16(18):3111. https://doi.org/10.3390/nu16183111

Forood AM. Mechanisms of telomere dysfunction in cancer from genomic instability to therapy: A. https://doi.org/10.30574/ijsra.2024.13.1.1731

Hussen BM, Taheri M, Yashooa RK, Abdullah GH, Abdullah SR, Kheder RK, Mustafa SA. Revolutionizing medicine: recent developments and future prospects in stem-cell therapy. International Journal of Surgery. 2024 Dec 1;110(12):8002-24.

https://doi.org/10.1097/JS9.0000000000002109

Grinin L, Grinin A, Korotayev A. Anti-aging as a Key Challenge for the Medicine of the Future. InCybernetic Revolution and Global Aging: Humankind on the Way to Cybernetic Society, or the Next Hundred Years 2024 May 18 (pp. 459-485). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-031-56764-3_11

Weth FR, Hoggarth GB, Weth AF, Paterson E, White MP, Tan ST, Peng L, Gray C. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy. British Journal of Cancer. 2024 Mar 23;130(5):703-15. https://doi.org/10.1038/s41416-023-02502-9

Tkemaladze J. Concept to The Eternal Youth. Longevity Horizons. 2025 Jan 18;108(1). https://doi.org/ 10.5281/zenodo.14681902

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2025 Asma Irfan